Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
Beom Kyung Kim(Yonsei University), Rohit Loomba(University of California San Diego), Nancy Sutter(University of California San Diego), Khang Nguyen(University of California San Diego), Xin Tu(China University of Geosciences), Nobuharu Tamaki(The Japanese Society of Gastroenterological Surgery), Claude B. Sirlin(University of California San Diego), Masato Yoneda(Yokohama City University Hospital), Kento Imajo(University of California San Diego), Tracy Le(University of California San Diego), Jinho Jung(University of California, Irvine), Mark A. Valasek(Sharp Memorial Hospital), Leyna Nguyen(University of California San Diego), Cynthia Behling(Johns Hopkins University), Jaclyn Bergstrom(University of Washington), Lin Tuo(Chongqing Medical University), Egbert Madamba(University of California San Diego), Lisa Richards(University of California San Diego), Atsushi Nakajima(Yokohama City University)
Cited by 105
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k